Company intelligence / Profile preview

InterBioScreen

Chernogolovka, Moscow Region, Russia

Ownership: Private
Employees: ~200
Development stage: Other

Overview

InterBioScreen provides vast and diverse libraries of synthetic and natural compounds for drug screening and discovery. It does not develop clinical drugs itself, but enables preclinical discovery for pharma, biotech, and academic partners globally. There are no reported clinical-stage assets.

Modalities: Small moleculeNatural productSynthetic compound
Industry: Drug Discovery Services

Beyond the preview

Go deeper on InterBioScreen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InterBioScreen.

Explore the full profile